← FDA Drug Approvals (Drugs@FDA)

ABREVA

NDA · New Drug Application · Sponsor: HALEON US HOLDINGS · Approved 2000-07-25

Drug application

FDA Application #

NDA020941

Application type

New Drug Application

Brand name

ABREVA

Generic name

DOCOSANOL

Active ingredients

DOCOSANOL

Dosage form

CREAM

Route

TOPICAL

Marketing status

Over-the-counter

Sponsor

HALEON US HOLDINGS

Manufacturer

Haleon US Holdings LLC

First approval

2000-07-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown